Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse osteosclerosis in hairy cell leukemia.

L A VanderMolen1, W J Urba, D L Longo

  • 1Biological Response Modifiers Program, National Cancer Institute, Frederick, MD 21701.

Blood
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial cells require functional FLVCR1a during developmental and adult angiogenesis.

Angiogenesis·2023
Same author

Complete on/off responsive ParaCEST MRI contrast agents for copper and zinc.

Dalton transactions (Cambridge, England : 2003)·2018
Same author

Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma.

Clinical pharmacology and therapeutics·2016
Same author

A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.

Leukemia·2014
Same author

Inhibition of experimental metastasis of human breast-carcinoma cells in athymic nude-mice by anti-alpha(5)beta(1) fibronectin receptor integrin antibodies.

International journal of oncology·2011
Same author

p52-Independent nuclear translocation of RelB promotes LPS-induced attachment.

Biochemical and biophysical research communications·2009
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

This study identifies a new syndrome linking diffuse osteosclerosis with hairy cell leukemia. Treatment of the leukemia stabilized bone density, suggesting a direct relationship between the cancer and bone disease.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Hairy cell leukemia is a rare B-cell malignancy.
  • Osteosclerosis is a condition characterized by increased bone density.

Observation:

  • Two patients presented with diffuse osteosclerosis and hairy cell leukemia.
  • Bone marrow biopsies were unobtainable due to bone hardness.
  • Neither patient reported bone pain or fractures.

Findings:

  • A novel clinical pathologic syndrome of diffuse osteosclerosis associated with hairy cell leukemia was observed.
  • Osteosclerosis stabilized in one patient following treatment with interferon alpha and deoxycoformycin for hairy cell leukemia.
  • This suggests a potential link between the hematologic malignancy and the bone pathology.

Related Experiment Videos

Implications:

  • This association may represent a new paraneoplastic syndrome.
  • Further research into the etiologic mechanisms is warranted.
  • Understanding this link could inform future treatment strategies for hairy cell leukemia patients with bone complications.